ATE83247T1 - Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen. - Google Patents

Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.

Info

Publication number
ATE83247T1
ATE83247T1 AT88850167T AT88850167T ATE83247T1 AT E83247 T1 ATE83247 T1 AT E83247T1 AT 88850167 T AT88850167 T AT 88850167T AT 88850167 T AT88850167 T AT 88850167T AT E83247 T1 ATE83247 T1 AT E83247T1
Authority
AT
Austria
Prior art keywords
hiv
infection
detection
synthetic peptide
peptide antigen
Prior art date
Application number
AT88850167T
Other languages
English (en)
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Syntello Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Ab filed Critical Syntello Ab
Application granted granted Critical
Publication of ATE83247T1 publication Critical patent/ATE83247T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88850167T 1987-05-18 1988-05-13 Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen. ATE83247T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/051,727 US4812556A (en) 1987-05-18 1987-05-18 Synthetic peptide antigen for the detection of HIV-2 infection
EP88850167A EP0292454B1 (de) 1987-05-18 1988-05-13 Synthetisches Peptid-Antigen für Nachweis von HIV-2-Infektionen

Publications (1)

Publication Number Publication Date
ATE83247T1 true ATE83247T1 (de) 1992-12-15

Family

ID=21973023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88850167T ATE83247T1 (de) 1987-05-18 1988-05-13 Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.

Country Status (11)

Country Link
US (1) US4812556A (de)
EP (1) EP0292454B1 (de)
AT (1) ATE83247T1 (de)
AU (1) AU606951B2 (de)
DE (1) DE3876496T2 (de)
DK (1) DK268588A (de)
ES (1) ES2011334A6 (de)
FI (1) FI882173A7 (de)
NO (1) NO881719L (de)
NZ (1) NZ224581A (de)
ZA (1) ZA883431B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
ES2054769T3 (es) * 1987-11-16 1994-08-16 Hoffmann La Roche Polipeptidos hiv-2 recombinantes.
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
US6214537B1 (en) * 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
EP0408663A4 (en) * 1988-04-07 1992-04-08 Univ Alabama Peptides inhibitors of hiv induced cell fusions and syncytia formation
EP0362927A3 (de) * 1988-10-06 1990-11-14 Akzo N.V. Mit HIV-Antikörpern immunochemisch reaktive synthetische Polypeptide
ATE135113T1 (de) * 1988-12-20 1996-03-15 Clarity Technologies Inc Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
CA2017021A1 (en) * 1989-05-22 1990-11-22 Johannes Jacobus Schalken Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
JPH0338599A (ja) * 1989-07-05 1991-02-19 Calpis Food Ind Co Ltd:The 抗ｈｉｖペプチド及び抗ｈｉｖ修飾ペプチド
US6083504A (en) * 1989-08-24 2000-07-04 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
US6008044A (en) * 1989-08-24 1999-12-28 Bioclonetics Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
CA2099367A1 (en) * 1991-11-04 1993-05-05 Dade International Inc. Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5420244A (en) * 1993-08-06 1995-05-30 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for diagnosing HTLV-I associated myelopathy and adult T-cell leukemia
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US6537631B1 (en) * 1999-04-30 2003-03-25 Kimberly-Clark Worldwide, Inc. Roll of wet wipes
ATE438883T1 (de) * 2001-09-04 2009-08-15 Wisconsin Alumni Res Found Flüssigkristallumschaltmechanismus
EP1438433A4 (de) * 2001-10-04 2005-12-21 Wisconsin Alumni Res Found Nachweis der hybridisierung von dna auf oberflächen
US7807348B2 (en) * 2002-03-20 2010-10-05 Wisconsin Alumni Research Foundation Optical imaging of nanostructured substrates
US7125592B2 (en) * 2002-04-10 2006-10-24 Wisconsin Alumni Research Foundation Detecting interactions at biomimetic interfaces with liquid crystals
WO2004044583A1 (en) * 2002-11-08 2004-05-27 Wisconsin Alumni Research Foundation Surfaces with gradients in surface topography
US7303694B2 (en) * 2003-07-17 2007-12-04 Wisconsin Alumni Research Foundation Liquid crystals with reduced toxicity and applications thereof
WO2005065121A2 (en) * 2003-12-02 2005-07-21 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
CA2554755A1 (en) * 2004-01-28 2005-08-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
WO2007111681A2 (en) * 2005-10-31 2007-10-04 Wisconsin Alumni Research Foundation Device and methods for liquid crystal-based bioagent detection
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
CA2700378A1 (en) * 2007-09-21 2009-03-29 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
EP2219458B1 (de) * 2007-11-08 2015-07-15 Cytimmune Sciences, Inc. Zusammensetzungen und verfahren für die erzeugung von antikörpern
US20130306629A1 (en) * 2012-05-21 2013-11-21 Hanna Asfaw Unity Cup

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320495B1 (de) * 1986-01-22 2000-08-02 Institut Pasteur Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert

Also Published As

Publication number Publication date
AU1645688A (en) 1988-11-24
EP0292454A2 (de) 1988-11-23
FI882173A0 (fi) 1988-05-10
FI882173L (fi) 1988-11-19
ZA883431B (en) 1988-11-17
FI882173A7 (fi) 1988-11-19
EP0292454A3 (en) 1989-10-04
DK268588D0 (da) 1988-05-17
DK268588A (da) 1988-11-19
DE3876496D1 (de) 1993-01-21
ES2011334A6 (es) 1990-01-01
NO881719L (no) 1988-11-21
DE3876496T2 (de) 1993-05-13
NZ224581A (en) 1990-09-26
NO881719D0 (no) 1988-04-21
AU606951B2 (en) 1991-02-21
EP0292454B1 (de) 1992-12-09
US4812556A (en) 1989-03-14

Similar Documents

Publication Publication Date Title
ATE83247T1 (de) Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.
ATE107663T1 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
ATE364621T1 (de) Hiv-peptide
EP0284587A3 (de) Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen
DK103085D0 (da) Hepatitis-b-peptidimmunogen
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
NO173958C (no) Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus
ATE7855T1 (de) Herstellung von virusantigenen.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
DE3672624D1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
SE8701294L (sv) Hiv-peptid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee